4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-22-000143
Options or other derivatives
- Chief Financial Officer acquired 1,250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Davis Blaine Chief Financial Officer | 2022-11-28 | Grant or award · Employee Stock Option (right to buy) | +1,250,000 | 1,250,000 | D | ||
Loading xslF345X03/wf-form4_166984440599363.xml…